Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.: EETs, Vascular Function, and Hypertension by Bellien, Jeremy et al.
Epoxyeicosatrienoic acids contribute with altered nitric
oxide and endothelin-1 pathways to conduit artery
endothelial dysfunction in essential hypertension.
Jeremy Bellien, Michele Iacob, Isabelle Remy-Jouet, Daniele Lucas, Christelle
Monteil, Laurence Gutierrez, Cathy Vendeville, Yvonne Dreano, Alain
Mercier, Christian Thuillez, et al.
To cite this version:
Jeremy Bellien, Michele Iacob, Isabelle Remy-Jouet, Daniele Lucas, Christelle Monteil, et
al.. Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways
to conduit artery endothelial dysfunction in essential hypertension.: EETs, Vascular Func-
tion, and Hypertension. Circulation, American Heart Association, 2012, 125 (10), pp.1266-75.
<10.1161/CIRCULATIONAHA.111.070680>. <inserm-00680446>
HAL Id: inserm-00680446
http://www.hal.inserm.fr/inserm-00680446
Submitted on 19 Sep 2012
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

Christian Thuillez and Robinson Joannides
Monteil, Laurence Gutierrez, Cathy Vendeville, Yvonne Dreano, Alain Mercier, 
Jeremy Bellien, Michele Iacob, Isabelle Remy-Jouet, Daniele Lucas, Christelle
Hypertension
Endothelin-1 Pathways to Conduit Artery Endothelial Dysfunction in Essential 
Epoxyeicosatrienoic Acids Contribute With Altered Nitric Oxide and
ISSN: 1524-4539 
Copyright © 2012 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online
72514
Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX
doi: 10.1161/CIRCULATIONAHA.111.070680
2012, 125:1266-1275Circulation 
 http://circ.ahajournals.org/content/125/10/1266
located on the World Wide Web at: 
The online version of this article, along with updated information and services, is
 http://www.lww.com/reprints
Reprints: Information about reprints can be found online at 
  
 journalpermissions@lww.com
410-528-8550. E-mail: 
Fax:Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. 
Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters
  
 http://circ.ahajournals.org//subscriptions/
Subscriptions: Information about subscribing to Circulation is online at 
 by guest on March 13, 2012http://circ.ahajournals.org/Downloaded from 
Vascular Medicine
Epoxyeicosatrienoic Acids Contribute With Altered Nitric
Oxide and Endothelin-1 Pathways to Conduit Artery
Endothelial Dysfunction in Essential Hypertension
Jeremy Bellien, PharmD, PhD; Michele Iacob, MD; Isabelle Remy-Jouet, PhD;
Daniele Lucas, PharmD, PhD; Christelle Monteil, PharmD, PhD; Laurence Gutierrez, MSN;
Cathy Vendeville, BSc; Yvonne Dreano, BSc; Alain Mercier, MD;
Christian Thuillez, MD, PhD; Robinson Joannides, MD, PhD
Background—We sought to clarify, using functional and biological approaches, the role of epoxyeicosatrienoic acids,
nitric oxide (NO)/reactive oxygen species balance, and endothelin-1 in conduit artery endothelial dysfunction during
essential hypertension.
Methods and Results—Radial artery diameter and mean wall shear stress were determined in 28 untreated patients with
essential hypertension and 30 normotensive control subjects during endothelium-dependent flow-mediated dilatation
induced by hand skin heating. The role of epoxyeicosatrienoic acids and NO was assessed with the brachial infusion of
inhibitors of cytochrome P450 epoxygenases (fluconazole) and NO synthase (NG-monomethyl-L-arginine [L-NMMA]).
Compared with controls, hypertensive patients exhibited a decreased flow-mediated dilatation in response to
postischemic hyperemia as well as to heating, as shown by the lesser slope of their diameter–shear stress relationship.
In controls, heating-induced flow-mediated dilatation was reduced by fluconazole, L-NMMA, and, to a larger extent,
by L-NMMAfluconazole. In patients, flow-mediated dilatation was not affected by fluconazole and was reduced by
L-NMMA and L-NMMAfluconazole to a lesser extent than in controls. Furthermore, local plasma epoxyeico-
satrienoic acids increased during heating in controls (an effect diminished by fluconazole) but not in patients. Plasma
nitrite, an indicator of NO availability, increased during heating in controls (an effect abolished by L-NMMA) and, to
a lesser extent, in patients, whereas, inversely, reactive oxygen species increased more in patients (an effect diminished
by L-NMMA). Plasma endothelin-1 decreased during heating in controls but not in patients.
Conclusions—These results show that an impaired role of epoxyeicosatrienoic acids contributes, together with an alteration
in NO/reactive oxygen species balance and endothelin-1 pathway, to conduit artery endothelial dysfunction in essential
hypertension.
Clinical Trial Registration—https://www.eudract.ema.europa.eu. Unique identifier: RCB2007-A001–10-53.
(Circulation. 2012;125:1266-1275.)
Key Words: arteries  endothelium-derived factors  epoxyeicosatrienoic acids  hypertension
The endothelium plays a crucial role in controllingvascular tone and homeostasis through the release of
vasoactive factors.1,2 In essential hypertension, endothelial
dysfunction is present in both resistance and conduit
arteries and constitutes an early independent predictor of
cardiovascular events.2,3 Moreover, it was prospectively
shown that the normalization of blood pressure with the
use of conventional antihypertensive drugs is associated
with a greater reduction in the occurrence of cardiovascu-
lar events when conduit artery endothelial function is
restored.3 Therefore, the restoration of conduit artery
endothelial function has emerged as a primary target to
limit cardiovascular morbidity and mortality in patients
with essential hypertension.
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However, the mechanisms of endothelial dysfunction, al-
though largely investigated in resistance arteries,4–8 have
been poorly documented at the level of the conduit arteries in
human hypertension. In fact, to our knowledge, the role of a
decrease in nitric oxide (NO) availability has only been
reported in 1 study.9 In addition, the evolution of the epoxyei-
cosatrienoic acid (EET) pathway has never been explored. This
is particularly important because EETs, which are synthesized
by endothelial cytochrome P450 epoxygenases, share with NO
many cardiovascular protective properties, contributing notably
to the regulation of vascular tone and remodeling. In addition,
increasing experimental evidence suggests that a decrease in
EET availability is involved in the pathophysiology of end-organ
damage in arterial hypertension.2,10 Furthermore, a role for the
vasoconstrictor endothelin-1 (ET-1) and reactive oxygen species
(ROS), which inactivate NO, in the endothelial dysfunction
associated with arterial hypertension remains to be clarified at
the level of the conduit arteries in humans.
In this context, the use of a sustained hyperemic stimula-
tion induced by the hand skin heating method may be
useful.11 Indeed, we demonstrated in healthy volunteers by
combining this method with functional approaches based on
the local inhibition of cytochrome P450 epoxygenases and
NO synthase that both pathways contribute to the regulation
of conduit artery flow-mediated dilatation.11 Moreover, be-
cause of the sustained and stable increase in blood flow, it is
possible to draw local blood samples during heating and thus
to putatively perform the biological identification of the
endothelial factors released.11
In this context, the present study was designed to compare,
with the use of functional and biological approaches, the role
of EETs, NO/ROS balance, and ET-1 during endothelium-
dependent flow-mediated dilatation in patients with essential
hypertension and normotensive control subjects.
Methods
Subjects
The study was performed in a total of 58 subjects. All subjects were
nonsmokers, must not have received hormone replacement therapies
or statins for the last 6 months, and did not receive any medication
at the time of the study.12 Subjects with cardiac and/or cerebrovascular
ischemic disease, heart failure, impaired renal function (estimated
glomerular filtration rate 60 mL/min per 1.73 m2 according to the
Cockcroft-Gault equation), or other major pathologies were excluded
from the study. Twenty-eight untreated patients with essential hyper-
tension were recruited from general practitioners of the local clinical
research network if supine systolic and diastolic blood pressures
measured after 10 minutes of rest were consistently found to be
140/90 mm Hg 3 times at 1- to 2-week intervals. Secondary forms of
hypertension were excluded by routine diagnostic procedures. Patients
were enrolled if never treated (n19) or reporting a medical history of
discontinued pharmacological antihypertensive treatment interrupted for
at least 3 months before the day of inclusion to exclude possible remnant
effects of the drugs on endothelial function (n9). Moreover, 30
volunteers frequency-matched for major vascular risk factors with the
hypertensive patients (Table) were recruited by the Centre
d’Investigation Clinique–Institut National de la Sante´ et de la Recherche
Me´dicale 0204 and the Department of Pharmacology of Rouen Univer-
sity Hospital and were deemed healthy on the basis of the absence of
familial history of essential hypertension and systolic and diastolic blood
pressure values 140/90 mm Hg, as well as complete medical exami-
nation and routine laboratory tests. On the day of inclusion, systolic and
diastolic blood pressures were measured after 10 minutes of rest on the
dominant arm by means of a brachial cuff oscillometric device (Omron
HEM-705CP) 3 times at 5-minute intervals. The study was approved
by the local ethics committee (Committee for the Protection of
Persons of Normandy), and all participants gave written informed
consent. The study was conducted according to the Principles of
Good Clinical Practice and the Declaration of Helsinki. The study
was registered at https://www.eudract.ema.europa.eu under the
unique identifier RCB2007-A001–10-53.
General Procedure
Measurements were performed in the morning while subjects were in
a supine position in a quiet air-conditioned room maintained at a
constant temperature (22°C to 24°C). Radial internal diameter, blood
flow, and digital arterial pressure were measured continuously on the
nondominant arm with a high-precision echo tracking device coupled
to a Doppler system (NIUS 02, Asulab) and a finger photoplethys-
mograph (Finapres System, Ohmeda).11
Assessment of Conduit Artery Endothelial
Dysfunction in Essential Hypertension Using
Postischemic Hyperemia and Hand Skin Heating
Peripheral conduit artery endothelial dysfunction has been demon-
strated in essential hypertension with the classic method of postis-
chemic hyperemia9 but not with the hand skin heating method.
Therefore, radial artery endothelial function was assessed in 12
hypertensive patients and 12 control subjects with the use of both
methods and by measuring endothelium-independent dilatation.
Postischemic Hyperemia
An arterial occlusion cuff was placed on the wrist, was inflated
50 mm Hg above systolic blood pressure for 10 minutes, and was
Table. Baseline Characteristics of Normotensive Control
Subjects and Hypertensive Patients
Parameters
Normotensive
Controls
(n30)
Hypertensive
Patients
(n28)
Age, y 489 5210
Male, n (%) 23 (77) 23 (82)
Body mass index, kg/m2 25.93.6 27.54.0
Systolic blood pressure, mm Hg 1248 16315*
Diastolic blood pressure, mm Hg 767 1009*
Heart rate, bpm 6310 7410*
Total cholesterol, mg/dL 20932 21730
LDL cholesterol, mg/dL 13928 14233
HDL cholesterol, mg/dL 5113 5218
Triglycerides, mg/dL 9648 11275
Fasting glucose, mg/dL 948 9912
Creatinemia, mg/dL 0.910.16 0.920.19
Estimated GFR, mL/min 10323 10729
Blood viscosity, cP 4.10.6 4.10.4
Radial artery diameter, mm 2.4350.352 2.4650.447
Radial artery blood flow, mL/min 12.25.2 13.95.6
Radial artery mean wall shear stress, kPa 5.02.2 5.72.3
Values are meanSD unless indicated otherwise. Statistical analyses of
high-density lipoprotein (HDL) cholesterol and triglycerides were performed on
log-transformed values, but the untransformed values are given in the table.
LDL indicates low-density lipoprotein; GFR, glomerular filtration rate.
*P0.05 vs normotensive controls.
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deflated to allow postischemic hyperemia with the continuous
measurements of all parameters. Postischemic hyperemia was char-
acterized by the peak flow (maximal increase in blood flow) and the
duration of the increase in flow (t1/2time elapsing between peak
hyperemia and return to 50% of this peak).
Hand Skin Heating
The hand skin temperature was modified by use of a water-filled
thermo-controlled device (Polystat 1, Bioblock Scientific). The hand
was introduced in the thermo-controlled tank by use of a thin
watertight glove fixed to the device. The device was then filled
with water, and the temperature was fixed to 34°C for 20 minutes.
Then hand skin heating was performed by gradually increasing the
water temperature from 34°C to 37°C, 40°C, and 44°C, with each
level of temperature maintained for 7 minutes. Total blood viscosity
was measured with a cone-plate viscometer (Ex100 CTB, Brook-
field) at a shear rate of 241 s1 at 37°C.11 From the individual values
of radial artery diameter (d), flow (Q), and total blood viscosity (),
the mean arterial wall shear stress was calculated on the basis of a
poiseuillean model {ie, [(4 Q)/(r3), (rd/2)]}, and the diam-
eter–shear stress relationships were constructed in hypertensive
patients and control subjects to compare these 2 groups at the same
level of stimulus.11
Endothelium-Independent Dilatation
Radial artery endothelium-independent dilatation was assessed with
the use of 0.3 mg sublingual glyceryl trinitrate.
Evolution of NO, EETs, ET-1, and ROS Pathways
During Heating-Induced Flow-Mediated Dilatation
in Essential Hypertension
The role of NO, EETs, ET-1, and ROS during heating was assessed
in 16 hypertensive patients and 18 control subjects by functional and
biological approaches.
Functional Approach
The forearm volume of each volunteer was measured by the water
displacement method to adjust the doses of the pharmacological
agents to be infused. A 27-gauge needle was inserted under local
anesthesia (1% lidocaine) into the brachial artery of the nondominant
arm to permit infusion of saline (0.9%) and pharmacological agents
at a constant rate (1 mL/min) with the use of dual programmable
syringe pumps (Vial Program 2, Becton Dickinson). Oral aspirin
(500 mg; BMS Laboratory) was administered to block the production
of vasomotor prostanoids.11 To assess the functional role of the EET
pathway in radial artery flow-mediated dilatation, heating was
performed during the infusion of saline and the inhibitor of cyto-
chrome P450 epoxygenases fluconazole (0.4–1.6 mol/min per liter;
Pfizer Holding).11 To assess the role of the NO pathway and whether
a contribution of the EET pathway may be unmasked under
conditions of reduced NO availability, heating was performed during
the infusion of saline, the NO synthase inhibitor NG-monomethyl-L-
arginine (L-NMMA) (8–20 mol/min per liter; Bachem), and
fluconazole associated with L-NMMA.11 Moreover, endothelium-
independent dilatation in response to sodium nitroprusside (from
5–20 nmol/min per liter; 3 minutes each dose) was assessed.11
Biological Approach
In addition to the functional approach, a 4F catheter was inserted into
the distal portion of the antecubital vein of the infused arm, when
accessible, allowing blood sampling in the venous return at 34°C and
44°C.11 Blood sampling was performed in the absence and in the
presence of fluconazole for the quantification of EET plasma level
by gas chromatography/mass spectrometry with negative-ion chem-
ical ionization,13 as well as in the absence and in the presence of
L-NMMA for the quantification of nitrite plasma level, used as
indicator of NO bioavailability, by a triiodide/ozone-based chemilu-
minescence assay.14
Moreover, ET-1 plasma levels were quantified with the use of a
human ET-1 EIA kit,15 and whole blood level of ROS was quantified
by electron paramagnetic resonance spectroscopy (Miniscope MS-
200, Magnettech).11 An expanded description of the biological
approach is available in the online-only Data Supplement.
Statistical Analysis
Statistics were performed with the SYSTAT package (SYSTAT 8.0;
SPSS). Continuous variables are presented as meanSD in the text
and as meanSEM in the figures, unless indicated differently. Quali-
tative variables are presented as absolute and relative frequencies.
Normality of data was assessed with the Shapiro-Wilk test, and a
logarithmic transformation was used to normalize distributions,
when appropriate. Differences between groups were assessed by
Fisher exact test for categorical variables and by 2-sample t test for
continuous variables. Analysis of flow-mediated dilatation induced
by postischemic hyperemia was repeated with ANOVA with group
as factor and with peak flow and duration of the increase in flow as
covariates. Differences between groups for the diameter–shear stress
relationship were assessed by ANOVA with the use of a generalized
linear model with group, shear stress, and subject as factors.
Differences between the effects of the inhibitors on the diameter–
shear stress relationship were assessed within group by ANOVA
with the use of a generalized linear model with inhibitor, shear stress,
and subject as factors followed, in case of significance, by a Tukey
test for post hoc pairwise comparisons. Differences within and
between groups for the reduction in the magnitude of flow-mediated
dilatation obtained with the inhibitors were assessed by ANOVA
with the use of a generalized linear model with group, inhibitor, and
subject as factors followed, in case of significance, by a Tukey test
for post hoc pairwise comparisons. In addition, the impact of blood
pressure levels on the magnitude of flow-mediated dilatation during
saline infusion and on the absolute change in flow-mediated dilata-
tion induced by fluconazole and L-NMMA was assessed by com-
paring these variables in the quartiles of diastolic blood pressure in
the whole population with a Kruskal-Wallis test followed, in case of
significance, by a Dunn test for post hoc pairwise comparisons.
Differences between biological markers levels at 34°C and 44°C
were assessed within groups under each inhibitor condition with a
paired t test. Differences within and between groups for the varia-
tions of biological markers levels between 34°C and 44°C were
assessed by ANOVA with a generalized linear model with group,
inhibitor, and subject as factors followed, in case of significance, by
a Tukey test for post hoc pairwise comparisons. Spearman rank
correlation coefficient (rs) was calculated to assess the correlation
between diastolic blood pressure obtained the day of inclusion and
functional and biological variables. Finally, Pearson correlation
analysis was performed to determine the linear relationship between
the variations in biological markers levels and the magnitude of
flow-mediated dilation during heating. A value of P0.05 was
considered statistically significant.
Results
There was no significant difference between hypertensive
patients and normotensive controls for demographic and
biological characteristics except for higher systolic and dia-
stolic blood pressures and higher heart rate in hypertensive
patients compared with normotensive controls (Table). In
addition, the basal radial artery diameter, blood flow, and
mean wall shear stress were similar in patients and controls.
Assessment of Conduit Artery Endothelial
Dysfunction in Essential Hypertension With the
Use of Postischemic Hyperemia and Hand
Skin Heating
Peak flow (Figure 1A) was not significantly different, but the
duration of the increase in flow (Figure 1B) and the magni-
tude of radial artery flow-mediated dilatation (Figure 1C)
obtained with postischemic hyperemia were reduced in hy-
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pertensive patients (n12) compared with normotensive
controls (n12). The difference between groups in the
magnitude of flow-mediated dilatation remained significant
after adjustment for peak flow and duration of the increase in
flow (P0.001).
There was a downward shift of the radial artery diameter–
mean wall shear stress relationship obtained during hand skin
heating in hypertensive patients (n12) compared with nor-
motensive controls (n12; Figure 1D). Thus, the magnitude
of radial artery flow-mediated dilatation (from 34° to 44°C)
was reduced in patients (0.3730.132 mm) compared with
controls (0.4840.104 mm; P0.03). The radial artery
endothelium-independent dilatation in response to glyceryl
trinitrate was not significantly different between groups
(Figure 1E).
Evolution of NO and EET Pathways During
Heating-Induced Flow-Mediated Dilatation in
Essential Hypertension
Functional Approach
Compared with saline, fluconazole induced a downward shift
of the radial artery diameter–mean wall shear stress relation-
ship in normotensive controls (n14) but not in hypertensive
patients (n11; Figure 2A). Thus, the magnitude of radial
artery flow-mediated dilatation (from 34° to 44°C) was reduced
by fluconazole in controls but not in patients (Figure 2B).
Compared with saline, L-NMMA and, to a larger extent,
L-NMMAfluconazole induced a downward shift of the
diameter–shear stress relationship in normotensive controls
(n14; Figure 3A). Thus, the magnitude of radial artery
flow-mediated dilatation was reduced by L-NMMA and, to a
larger extent, by L-NMMAfluconazole in controls (Figure
3B). In contrast, L-NMMA and L-NMMAfluconazole in-
duced a similar downward shift of the diameter–shear stress
relationship in hypertensive patients (n13). Thus, the mag-
nitude of radial artery flow-mediated dilatation was reduced
similarly by L-NMMA and L-NMMAfluconazole in pa-
tients. Moreover, the decrease in flow-mediated dilatation
induced by L-NMMA was lesser in patients than in controls.
In the entire population, there was a significant decrease in
the magnitude of flow-mediated dilatation under saline infu-
sion as well as in the absolute change in flow-mediated
dilatation induced by fluconazole and L-NMMA with the
increase in diastolic blood pressure (Figure 4A through 4C).
The radial artery endothelium-independent dilatation in
response to sodium nitroprusside was not significantly differ-
Figure 1. Bar graphs show (A) peak radial artery blood flow, (B) time to return to 50% from peak flow (t1/2), (C) magnitude of radial
artery flow-mediated dilatation during postischemic hyperemia, and (E) radial artery endothelium-independent dilatation to glyceryl trini-
trate in 12 normotensive controls and 12 essential hypertensive patients. D, Line graph shows radial artery diameter–mean wall shear
stress relationships obtained during hand skin heating in the same subjects of the 2 groups. The altered radial artery flow-mediated
dilatation in response to postischemic hyperemia in the presence of reduced hyperemia (ie, t1/2 of flow) in hypertensive patients com-
pared with controls is confirmed with consideration of the flow stimulus (ie, wall shear stress) by the downward shift of the diameter–
shear stress relationship. P0.001, shear stress effect; *P0.05 vs normotensive controls.
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ent in hypertensive patients and normotensive controls (Fig-
ure I in the online-only Data Supplement).
Biological Approach
The basal EET plasma level was not significantly different in
normotensive controls (12.84.5 ng/mL; n9) and in hyperten-
sive patients (13.94.0 ng/mL; n9; P0.27). However, hand
skin heating induced an increase in local plasma EET level only
in controls (Figure 5A). This increase was reduced but not
abolished by fluconazole. In the entire population, the variation
in plasma EET level during heating was inversely correlated
with diastolic blood pressure (rs0.61, P0.009).
The basal nitrite plasma level was lower in hypertensive
patients (14025 nmol/L; n7) than in normotensive con-
trols (17630 nmol/L; n7; P0.049). Heating induced an
increase in local plasma nitrite level in both groups, but this
increase was lesser in hypertensive patients (Figure 5B).
The increase in nitrite was abolished in both groups by
L-NMMA. In the entire population, the variation in plasma
nitrite level during heating was inversely correlated with
diastolic blood pressure (rs0.71, P0.013).
The basal ET-1 plasma level was not significantly different
under our experimental conditions in normotensive controls
(2.50.8 pmol/L; n9) and in hypertensive patients
(3.21.0 pmol/L; n9; P0.13), but hand skin heating
induced a decrease in local plasma ET-1 level in controls but
not in patients (Figure 6A). In the entire population, there was
a significant decrease in the variation of plasma ET-1 during
heating with the increase in diastolic blood pressure (rs
0.65, P0.009; Figure 6B). Moreover, the decrease in ET-1
during heating in normotensive controls was not significantly
affected by fluconazole (n5) or by L-NMMA (n5; Figure
IIA and IIB in the online-only Data Supplement).
The basal ROS blood level was not significantly different
between normotensive controls (34.66.9 mol/L; n7) and
Figure 2. A, Line graphs show radial artery diameter–mean wall shear stress relationships obtained during hand skin heating in the
presence of saline and fluconazole in normotensive controls and essential hypertensive patients. B, Bar graph represents the reduction
obtained with fluconazole in the magnitude of radial artery flow-mediated dilatation compared with saline in the same subjects of the 2
groups. Fluconazole induced a significant downward shift of the diameter–shear stress relationship in normotensive controls but not in
hypertensive patients. Thus, fluconazole reduced the magnitude of radial artery flow-mediated dilatation to a larger extent in normoten-
sive controls than in hypertensive patients (B). P0.001, shear stress effect; *P0.001 vs saline; †P0.05 vs normotensive controls.
Figure 3. A, Line graphs show radial artery diameter–mean wall shear stress relationships obtained during hand skin heating in the
presence of saline, NG-monomethyl-L-arginine (L-NMMA), and L-NMMAfluconazole in normotensive controls and essential hyperten-
sive patients. B, Bar graph represents the reduction obtained with L-NMMA and L-NMMAfluconazole in the magnitude of radial artery
flow-mediated dilatation in the same subjects of the 2 groups. L-NMMA induced a downward shift of the diameter–shear stress rela-
tionship in normotensive controls and in hypertensive patients, but L-NMMAfluconazole induced a more pronounced downward shift
than L-NMMA alone only in controls. Thus, L-NMMAfluconazole reduced the magnitude of radial artery flow-mediated dilatation to a
larger extent than L-NMMA alone in controls but not in hypertensive patients. Moreover, the reduction in the magnitude of radial artery
flow-mediated dilatation obtained with L-NMMA was more marked in controls than in patients. P0.001, shear stress effect; *P0.001
vs saline; †P0.01 vs L-NMMA; ‡P0.05 vs normotensive controls.
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hypertensive patients (34.813.6 mol/L; n7; P0.98).
Heating induced an increase in blood ROS level in both
groups, but this increase was higher in hypertensive patients
(Figure 7). The increase in ROS was reduced by L-NMMA in
patients but not in controls and was abolished in both groups
by L-NMMAfluconazole. Moreover, the increase in ROS
during heating was similarly reduced by fluconazole alone in
normotensive controls and in hypertensive patients (Figure III
in the online-only Data Supplement).
Finally, the magnitude of radial artery flow-mediated
dilatation induced by heating during saline infusion in the
population of hypertensive patients and normotensive con-
trols was positively correlated with nitrite variation (n14;
r0.65, P0.008) and negatively correlated with the varia-
tions of ET-1 (n18; r0.47, P0.046) and ROS but did
not reach statistical significance (n14; r0.45, P0.08;
Figure IVA through IVC in the online-only Data Supple-
ment). In addition, the magnitude of flow-mediated dilatation
was negatively correlated with EET variation during heating
but only in normotensive controls (n9; r0.63, P0.055;
Figure IVD in the online-only Data Supplement).
Discussion
The major finding of this study is that the decrease in
flow-mediated dilatation of peripheral conduit arteries in
patients with essential hypertension is due to an imbalance
between endothelium-derived relaxing and constricting fac-
tors, characterized by the abrogation of the EET pathway, an
altered NO/ROS balance, and an associated absence of
adaptation of the ET-1 pathway to flow increase.
First, we validated hand skin heating as a useful tool to
detect conduit artery endothelial dysfunction in patients with
essential hypertension. Indeed, we observed that the radial
artery flow-mediated dilatation was decreased in patients in
response to heating as well as in response to the more
commonly used method of postischemic hyperemia, without
modification in the smooth muscle cell reactivity. Interest-
ingly, although peak flow was preserved, we noticed that
there was a decrease in the duration of the increase in flow
during postischemic hyperemia in our patients.16 As stressed
previously, this may be due to an imbalance between vaso-
constrictor and vasodilator influences and thus may reflect
the presence of an arteriolar endothelial dysfunction shorten-
ing the time to return to baseline tone and flow.17 Although
the difference between groups for flow-mediated dilatation
persists after statistical adjustment, this reduced hyperemia
probably contributed to the decrease in the endothelial re-
sponse.18 In this context, the downward shift of the diameter–
shear stress relationship obtained in hypertensive patients
Figure 4. Box plots of (A) the magnitude of flow-mediated dilatation induced by hand skin heating during saline infusion and of the
reduction in the magnitude of flow-mediated dilatation obtained with (B) fluconazole and with (C) NG-monomethyl-L-arginine (L-NMMA)
as a function of the quartiles of diastolic blood pressure in the population of patients with essential hypertension and normotensive
controls. The magnitude of flow-mediated dilatation during saline infusion as well as the effects of the 2 inhibitors on this parameter
decreased with the increase in diastolic blood pressure. Box plots with medians, first and third quartiles, and fifth and 95th percentiles
are shown. K.W. indicates Kruskal-Wallis test; rs, Spearman rank correlation coefficient.
Figure 5. Bar graphs show variations in the plasma levels (A) of epoxyeicosatrienoic acids (EETs) during hand skin heating in the pres-
ence of saline and fluconazole and (B) of nitrite in the presence of saline and NG-monomethyl-L-arginine (L-NMMA) in normotensive
controls and patients with essential hypertension. EETs increased during heating in controls but not in hypertensive patients, and this
increase was reduced by fluconazole. In addition, nitrite increased during heating in both groups but to a lesser extent in patients, and
these increases were abolished by L-NMMA. *P0.05 vs baseline; †P0.05 vs saline; ‡P0.05 vs normotensive controls.
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during heating compared with controls confirms, by directly
taking into account the flow stimulus, the presence of this
endothelial dysfunction.
In regard to the NO pathway, we confirmed in our
normotensive controls the physiological role of NO in the
regulation of conduit artery flow-mediated dilatation.11,17
Indeed, the pharmacological inhibition of NO synthase with
L-NMMA was associated with a downward shift of the
diameter–shear stress relationship during heating. Accord-
ingly, the local plasma nitrite level increased during heating
under saline infusion, as shown previously during postische-
mic hyperemia,19 but we also demonstrated that these nitrites
originated from NO produced by NO synthase because the
nitrite level was no longer increased in the presence of
L-NMMA. In hypertensive patients, there was a lesser basal
nitrite plasma concentration compared with control subjects,
confirming biologically the decrease in basal NO availability
during this disease.4,5,9 In this respect, previous data have
demonstrated an inverse correlation between nitrite level and
the number of cardiovascular risk factors, including hyper-
tension.20 Moreover, L-NMMA reduced flow-mediated dila-
tation and local plasma nitrite level also increased during
heating in patients, but these effects were significantly less
marked than in control subjects, showing that an alteration in
the NO pathway contributes to the endothelial dysfunction of
conduit arteries during essential hypertension. These results
are in agreement with a previous functional study demon-
strating the absence of an inhibitory effect of L-NMMA on
flow-mediated dilatation in patients with essential hyperten-
sion but in response to less sustained stimulation induced by
postischemic hyperemia.9
Furthermore, using the biological approach, we observed,
in accordance with our previous results obtained in healthy
subjects, that ROS increased during heating in both studied
groups.11 However, this increase was higher in patients than
in controls, although basal levels were similar, and this
between-group difference was abolished by L-NMMA. These
results strongly support the hypothesis that increased ROS
production originating from uncoupled NO synthase contrib-
uted to the endothelial dysfunction of conduit arteries in our
patients, in accordance with several animal observations.21
Conversely, a role for cytochrome P450 epoxygenases in this
increased ROS production, a mechanism contributing to the
endothelial dysfunction of resistance arteries in patients with
coronary artery disease,22 appears not to be involved. In fact,
fluconazole either alone or associated with L-NMMA simi-
larly reduced ROS production in both groups. Moreover, this
last result is in accordance with our previously reported data
suggesting that a physiological production of ROS by a
cytochrome P450–dependent mechanism occurs in cutane-
ous resistance arteries to limit the skin arteriolar dilatation
during heating.11
In regard to the EET pathway, we confirmed in controls the
physiological role of cytochrome P450 epoxygenases in the
regulation of conduit artery flow-mediated dilatation,11,23 as
illustrated by the downward shift of the diameter–shear stress
relationship induced by fluconazole during heating, infused
either alone or in the presence of L-NMMA. Moreover, we
provided for the first time in humans in vivo strong evidence
Figure 6. A, Bar graph shows variations in the plasma level of endothelin-1 (ET-1) during hand skin heating in the presence of saline in
normotensive controls and patients with essential hypertension. During heating, plasma ET-1 decreased in controls but not in hyperten-
sive patients. *P0.05 vs baseline, †P0.05 vs normotensive controls. B, Box plot of variations in ET-1 level during hand skin heating
in the presence of saline as a function of the quartiles of diastolic blood pressure in the population of patients with essential hyperten-
sion and normotensive controls. The magnitude of ET-1 reduction during hand skin heating decreased with the increase in diastolic
blood pressure. Box plot with medians, first and third quartiles, and fifth and 95th percentiles is shown. K.W. indicates Kruskal-Wallis
test; rs, Spearman rank correlation coefficient.
Figure 7. Bar graph shows variations in the whole blood level of
reactive oxygen species (ROS) during hand skin heating in the
presence of saline, NG-monomethyl-L-arginine (L-NMMA), and
L-NMMAfluconazole in normotensive controls and patients
with essential hypertension. ROS increased during heating in
controls and, to a larger extent, in hypertensive patients. This
increase was reduced by L-NMMA in patients but not in con-
trols, whereas L-NMMAfluconazole similarly reduced ROS in
both groups. *P0.05 vs baseline; †P0.05 vs normotensive
controls; ‡P0.05 vs saline; §P0.05 vs L-NMMA.
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that EETs are the factors produced by cytochrome P450
epoxygenases mediating this response. Indeed, we observed
that the local EET plasma concentration increased during the
flow stimulation and that this increase was impaired by
fluconazole. Interestingly, the increase in EET level was
reduced but not abolished by fluconazole, suggesting, as
shown in animals, the presence of an intracellular storage
form of EETs into phospholipids, which can be liberated on
cell activation independently of cytochrome P450 epoxygen-
ase activity.24 In hypertensive patients, the basal EET plasma
level was similar to that of control subjects according to 1
reported study, which demonstrated with the use of biological
quantification that the alteration in basal EET availability can
only be significantly detected in renovascular hypertensive
patients.25 However, we no longer observed in patients a
reduction in flow-mediated dilatation with fluconazole alone
or even associated with L-NMMA or an increase in the local
EET plasma level during heating, demonstrating for the first
time that, in addition to NO, an impairment in EET pathway
contributes to the conduit artery endothelial dysfunction
during essential hypertension. This impairment in EET path-
way during arterial hypertension has been suggested previ-
ously from animal experiments and notably may be due to an
increased degradation of EETs by soluble epoxide hydro-
lase.2,10,26 Conversely, an increased role of cytochrome P450
epoxygenases in endothelium-dependent dilatation was reported
at the level of forearm resistance arteries in patients with
essential hypertension compared with normotensive controls,
which compensates for the decrease in NO availability.8
Whether these discrepancies are related to differences in the
vascular beds studied or to the grade and/or duration of hyper-
tension of patients remains to be investigated.
Furthermore, in accordance with most of the previous
studies,27,28 we observed a slightly higher basal ET-1 plasma
level in our hypertensive patients compared with controls,
although this was not significant under our experimental
conditions. However, as stressed previously,28 because endo-
thelium-derived ET-1 has a predominantly paracrine action,
its basal plasma level does not necessarily represent the
degree of activation of the endothelin system. Most interest-
ing, we observed that plasma ET-1 availability decreases
during flow stimulation in controls but not in patients. It must
be stressed that the studies evaluating the role of shear stress
in the modulation of ET-1 release by the endothelium are
controversial and are probably influenced by experimental
conditions.29 In fact, the level, duration, and steady or
pulsatile application of shear stress as well as the cell type and
species studied may influence the results.29 Nonetheless, 1
study has demonstrated in vivo in healthy volunteers, with the
use of local infusion of a blocker of the ET-1 type A receptor,
that ET-1 acutely mediates the radial artery constriction
associated with conditions of reduced flow induced by distal
ischemia.30 This result, suggesting an increased availability of
ET-1 during conditions of reduced shear stress, supports our
hypothesis (ie, a decreased availability of ET-1 with in-
creased shear stress). Importantly, this mechanism appears to
be lost in hypertensive patients and thus could contribute to
aggravate the conduit artery endothelial dysfunction by ex-
acerbating the vasoconstrictor influence of ET-1. Thus, the
administration of newly developed ET-1 receptor antagonists,
which have recently been shown to improve blood pressure
control in resistant hypertension,31 may also be useful to
prevent residual conduit artery endothelial dysfunction during
essential hypertension, as shown in forearm arterioles.7 Fur-
thermore, this absence of decrease in ET-1 during flow
stimulation in patients may be related to the decrease in the
availability of NO, which can acutely impair ET-1 release.32
However, NO-independent mechanisms directly mediated by
shear stress are probably involved, as observed previously in
primary culture of human umbilical veins,33 because the
inhibition of NO synthase in our healthy controls did not
abolish the decrease in ET-1 variation during heating. In the
same way, the decreased availability of EETs is probably not
involved because the inhibition of cytochrome P450 epoxy-
genases by fluconazole did not affect ET-1 variation in
controls. Additional experiments are necessary to explore the
interplay between EETs and ET-1 pathways, as stressed
previously with the use of ET-1 receptor antagonists and/or
infusion of synthetic EET analogues, which are currently
under development but not available for human use.
Finally, in addition to demonstrating the presence of these
alterations in EETs, NO, and ET-1 pathways in patients with
essential hypertension at the level of the conduit arteries, our
results show, in the entire population studied, a progressive
impairment of these pathways, with the increase in blood
pressure levels thus contributing to reduce endothelium-
dependent flow-mediated dilatation.
In conclusion, our results demonstrate that an impaired role
of EETs contributes, with an alteration in NO and ET-1
pathways, to conduit artery endothelial dysfunction in essen-
tial hypertension. In this context, restoring the EET pathway
may be useful to prevent conduit artery endothelial dysfunc-
tion during essential hypertension; this thus represents a new
therapeutic target that may be useful to improve the cardio-
vascular prognosis in patients.
Study Limitations
Average levels of total and low-density lipoprotein choles-
terol were borderline high according to American Heart
Association guidelines in our study participants. However,
these levels were similar between groups and were associated
with normal values of high-density lipoprotein cholesterol,
thus probably not affecting sustained conduit artery flow-
mediated dilatation.34 Furthermore, blood sampling was per-
formed in the venous return, and thus measured factors may
originate from distal vascular compartments. However, the
magnitude of flow-mediated dilatation was positively corre-
lated with nitrite variation and negatively correlated with
ET-1 and ROS variations, showing that a significant part of
these factors originates from the studied conduit artery.19
Finally, in an unexpected way, there was a negative correla-
tion between the radial artery dilatation and EET variation in
healthy subjects. Although dedicated experiments are war-
ranted, this result may reflect a compensatory increased
release of EETs, which may help to maintain the vasodilator
function in subjects with incipient alteration in endothelial
function, in particular during aging, whereas this mechanism
is lost in hypertensive patients. Accordingly, we noticed that
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the decrease in flow-mediated dilatation obtained with flu-
conazole was 25% higher in the subjects explored in the
present study (125 m) than in the younger healthy
subjects (mean age of 25 years) previously explored
(100 m), whereas, at the same time, the magnitude of the
dilatory response decreased by 20% in older subjects (620
versus 500 m).11 Furthermore, we cannot exclude that
fluconazole affected pathways other than EETs. However,
this appears unlikely under our experimental conditions
because fluconazole reduced flow-mediated dilatation even
when infused with L-NMMA and did not affect the decrease
in plasma ET-1 during heating in control subjects, suggesting
the absence of effects on NO and ET-1 pathways.
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CLINICAL PERSPECTIVE
Patients with essential hypertension are at increased cardiovascular risk even when their blood pressure levels are well
controlled, and restoration of the endothelial function of conduit arteries has emerged as a therapeutic target that may help
to prevent the development of cardiovascular complications. In the present study, we demonstrated that several
mechanisms contribute to conduit artery endothelial dysfunction in hypertensive patients. In addition to nitric oxide/
reactive oxygen species imbalance and alteration in the endothelin-1 pathway, a decrease in epoxyeicosatrienoic acid
availability is involved. This is particularly important because epoxyeicosatrienoic acids are not only endothelium-derived
relaxing factors, but they also play a major role in maintaining cardiovascular homeostasis by contributing to the regulation
of vascular inflammation, cell proliferation, angiogenesis, and hemostasis. Consequently, a new class of pharmacological
agents referred to as soluble epoxide hydrolase inhibitors is under development. Therefore, to increase epoxyeicosatrienoic
acid availability by reducing their degradation may be particularly useful during essential hypertension. Thus, in addition
to decreasing blood pressure, epoxyeicosatrienoic acids could restore the protective action of the endothelium in conduit
arteries and prevent the development of atherosclerosis and cardiovascular complications.
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